Drugs of the Future 2008, 33(2): 149-155 © 2008 Prous Science, S.A.U. or its licensors. All rights reserved. CCC: 0377-8282/2008 DOI: 10.1358/dof.2008.033.02.1173290 Review Article Compounds for dementia from Hericium erinaceum Hirokazu Kawagishi1,2,*, Cun Zhuang3 1Graduate School of Science and Technology, Shizuoka University, Shizuoka 422-8529, Japan; 2Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan; 3Bio Research Institute, New Jersey, USA. *Correspondence:
[email protected] CONTENTS protection against neuronal cell death caused by oxida- tive or endoplasmic reticulum (ER) stress (8-10); 3) anti- Abstract . tumor activity (11); 4) anti-HIV activity (12); 5) immune Introduction . enhancement (13-15); 6) hemagglutinating activity (16, NGF and AD . 17); 7) cytotoxicity against cancer cells (18-20); 8) antimi- Hericenones . crobial activity (21-23); 9) hypoglycemic effects (24); and Erinacines . Bioactivities of hericenones and erinacines . 10) hypolipidemic effects (25). Aβ and AD . Alzheimer’s disease (AD) is the most common form of DLPE . dementia, causing memory loss, language deterioration, Bioactivities of DLPE . impaired ability to manipulate visual information mentally, Preliminary clinical trials . poor judgement, confusion, restlessness and mood Conclusions . swings due to progressive neurodegeneration. It eventu- References . ally leads to the loss of cognition, personality and func- tion. It has been reported that the susceptibility to AD is closely related to a number of factors, including age, Abstract genes, lack of NGF and excessive accumulation of Aβ. Conventional treatments for AD only address the symp- Our group has been conducting a search for com- toms, but there is presently no cure.